VIENNA, 25 June 2020 – Around 269 million people used drugs worldwide in 2018, which is 30 per cent more than in 2009, while over 35 million people suffer from drug use disorders, according to the latest World Drug Report, released today by the United Nations Office on Drugs and Crime (UNODC). The Report also analyses the impact of COVID-19 on the drug markets, and while its effects are not yet fully known, border and other restrictions linked to the pandemic have already caused shortages of drugs on the street, leading to increased prices and reduced purity.
Rising unemployment and reduced opportunities caused by the pandemic are also likely to disproportionately affect the poorest, making them more vulnerable to drug use and also to drug trafficking and cultivation in order to earn money, the Report says.
“Vulnerable and marginalized groups, youth, women and the poor pay the price for the world drug problem. The COVID-19 crisis and economic downturn threaten to compound drug dangers further still, when our health and social systems have been brought to the brink and our societies are struggling to cope,” said UNODC Executive Director Ghada Waly. “We need all governments to show greater solidarity and provide support, to developing countries most of all, to tackle illicit drug trafficking and offer evidence-based services for drug use disorders and related diseases, so we can achieve the Sustainable Development Goals, promote justice and leave no one behind.”
Due to COVID-19, traffickers may have to find new routes and methods, and trafficking activities via the darknet and shipments by mail may increase, despite the international postal supply chain being disrupted. The pandemic has also lead to opioid shortages, which in turn may result in people seeking out more readily available substances such as alcohol, benzodiazepines or mixing with synthetic drugs. More harmful patterns of use may emerge as some users switch to injecting, or more frequent injecting.
Looking at further effects of the current pandemic, the Report says that if governments react the same way as they did to the economic crisis in 2008, when they reduced drug-related budgets, then interventions such as prevention of drug use and related risk behaviours, drug treatment services, the provision of naloxone for management and reversal of opioid overdose could be hard hit. Interception operations and international cooperation may also become less of a priority, making it easier for traffickers to operate.
Trends in drug use
Cannabis was the most used substance worldwide in 2018, with an estimated 192 million people using it worldwide. Opioids, however, remain the most harmful, as over the past decade, the total number of deaths due to opioid use disorders went up 71 per cent, with a 92 per cent increase among women compared with 63 per cent among men.
Drug use increased far more rapidly among developing countries over the 2000-2018 period than in developed countries. Adolescents and young adults account for the largest share of those using drugs, while young people are also the most vulnerable to the effects of drugs because they use the most and their brains are still developing.
Cannabis trends
While the impact of laws that have legalized cannabis in some jurisdictions is still hard to assess, it is noteworthy that frequent use of cannabis has increased in all of these jurisdictions after legalization. In some of these jurisdictions, more potent cannabis products are also more common in the market.
Cannabis also remains the main drug that brings people into contact with the criminal justice system, accounting for more than half of drug law offences cases, based on data from 69 countries covering the period between 2014 and 2018.
Availability of pharmaceutical opioids for medical consumption varies across the globe
The Report also points out that low-income countries still suffer a critical shortage of pharmaceutical opioids for pain management and palliative care. More than 90 per cent of all pharmaceutical opioids available for medical consumption were in high-income countries in 2018 comprising around 12 per cent of the global population, while the low and middle-income countries comprising 88 per cent of the global population are estimated to consume less than 10 percent of pharmaceutical opioids. Access to pharmaceutical opioids depend on several factors including legislation, culture, health systems and prescribing practices.
Socio-economically disadvantaged face greater risk from drug use disorders
Poverty, limited education and social marginalization remain major factors increasing the risk of drug use disorders and vulnerable and marginalized groups may also face barriers to getting treatment services due to discrimination and stigma.
***
The World Drug Report and further content is available here: wdr.unodc.org
The 2020 World Drug Report provides a global overview of the supply and demand of opiates, cocaine, cannabis, amphetamine-type stimulants and new psychoactive substances (NPS), as well as their impact on health, taking into account the possible effects of the COVID-19 pandemic. It highlights, through improved research and more precise data, that the adverse health consequences of drug use are more widespread than previously thought.
* *** *
For further information please contact:
Brian Hansford
Chief, UNODC Advocacy Section
Mobile: (+43-699) 1458-3225
Email: brian.hansford[at]un.org
